Lv21
118 积分 2024-02-02 加入
Trends in the approval of cancer therapies by the FDA in the twenty-first century
3小时前
待确认
SH3GL1 mediates B7-H3 recycling and enhances the immune escape in non-small cell lung cancer
13天前
已完结
Design, Synthesis and Evaluation of Novel 1,3-Benzodioxole Derivatives for Their Anti-Tumor Activity
15天前
已完结
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
17天前
已完结
Integrated radio-theranostics using a [ 89 Zr]Zr-/[ 177 Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer
18天前
已关闭
Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
24天前
已完结
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
24天前
已完结
Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA
24天前
已完结
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
25天前
已完结
TL1A Induces TCR Independent IL-6 and TNF-α Production and Growth of PLZF+ Leukocytes
27天前
已关闭
皖公网安备34019202002308
